Literature DB >> 22204070

Attempted in vitro maturation and fertilization of postmortem Sumatran rhinoceros (Dicerorhinus sumatrensis) oocytes.

Monica A Stoops1, Helen L Bateman, Mark K Campbell, Terri L Roth.   

Abstract

A study was conducted opportunistically to evaluate the potential of rescuing immature oocytes from the ovaries of the Sumatran rhinoceros postmortem. Recovered oocytes (n = 30) were placed in maturation culture for 36 hr and inseminated with frozen-thawed homologous spermatozoa. After culture, evaluation of nuclear maturation status revealed that a large number of oocytes were degenerated (n = 21), but nine oocytes were assessed at the germinal vesicle (n = 3), metaphase I (n = 3), and metaphase II (n = 3) stages. Frozen-thawed Sumatran rhinoceros spermatozoa were capable of binding to the zona pellucida of in vitro matured oocytes, but no fertilization or cleavage resulted. In conclusion, relatively large numbers of oocytes can be obtained by ovarian follicular aspiration postmortem in the Sumatran rhinoceros, and some of these oocytes are capable of achieving nuclear maturation in vitro. However, additional studies are required to improve maturation success and achieve fertilization in culture.

Entities:  

Mesh:

Year:  2011        PMID: 22204070     DOI: 10.1638/2010-0186.1

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  3 in total

1.  Endangered species: Sex and the single rhinoceros.

Authors:  Henry Nicholls
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  Rhinos in the Parks: An Island-Wide Survey of the Last Wild Population of the Sumatran Rhinoceros.

Authors:  Wulan Pusparini; Paul R Sievert; Todd K Fuller; Timothy O Randhir; Noviar Andayani
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

3.  Freezing African elephant semen as a new population management tool.

Authors:  Robert Hermes; Joseph Saragusty; Frank Göritz; Paul Bartels; Romain Potier; Barbara Baker; W Jürgen Streich; Thomas B Hildebrandt
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.